These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


214 related items for PubMed ID: 20833122

  • 1. The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines.
    Feng F, Teoh CQ, Qiao Q, Boyle D, Jilbert AR.
    Vaccine; 2010 Oct 28; 28(46):7436-43. PubMed ID: 20833122
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
    Miller DS, Halpern M, Kotlarski I, Jilbert AR.
    Virology; 2006 May 10; 348(2):297-308. PubMed ID: 16469347
    [Abstract] [Full Text] [Related]

  • 4. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner.
    Miller DS, Kotlarski I, Jilbert AR.
    Virology; 2006 Jul 20; 351(1):159-69. PubMed ID: 16624364
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genes.
    Saade F, Buronfosse T, Pradat P, Abdul F, Cova L.
    Vaccine; 2008 Sep 19; 26(40):5159-64. PubMed ID: 18554756
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.
    Foster WK, Miller DS, Scougall CA, Kotlarski I, Colonno RJ, Jilbert AR.
    J Virol; 2005 May 19; 79(9):5819-32. PubMed ID: 15827196
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enhanced magnitude and breadth of neutralizing humoral response to a DNA vaccine targeting the DHBV envelope protein delivered by in vivo electroporation.
    Khawaja G, Buronfosse T, Jamard C, Guerret S, Zoulim F, Luxembourg A, Hannaman D, Evans C, Hartmann D, Cova L.
    Virology; 2012 Mar 30; 425(1):61-9. PubMed ID: 22284894
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
    Le Mire MF, Miller DS, Foster WK, Burrell CJ, Jilbert AR.
    J Virol; 2005 Oct 30; 79(19):12242-52. PubMed ID: 16160150
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks.
    Jilbert AR, Miller DS, Scougall CA, Turnbull H, Burrell CJ.
    Virology; 1996 Dec 15; 226(2):338-45. PubMed ID: 8955053
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Viral load in 1-day-old ducklings acutely infected with duck hepatitis B virus by different doses and routes of inoculation.
    Chen ZY, Cheng AC, Wang MS, Xu DW, Jia R, Guo YF, Zeng W.
    Avian Pathol; 2009 Apr 15; 38(2):129-34. PubMed ID: 19322711
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.